drugset

drugset / Trial / NCT06849973

To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome

NCT06849973 ↗

Phase 2/3 Completed 187 enrolled Biomed Industries, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To study the efficacy \& safety of oral Bionetide versus placebo in girls and women with Rett syndrome

Timeline

Start: 2024-03-15
Primary completion: 2024-11-22
Completion: 2025-01-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bionetide	Unknown	—	Oral

Indications